Analysts at Craig-Hallum Reconfirmed their Buy rating for Everspin Technologies (MRAM). The PT is $14.0; Wesbanco Bank Boosted Bristol (BMY) Stake

November 15, 2017 - By Marguerite Chambers

Among 4 analysts covering Everspin Technologies (MRAM), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Everspin Technologies has $14 highest and $10.0 lowest target. $11.67’s average target is 41.28% above currents $8.26 stock price. Everspin Technologies had 4 analyst reports since November 2, 2016 according to SRatingsIntel. The company was initiated on Wednesday, November 2 by Stifel Nicolaus. Needham initiated Everspin Technologies Inc (NASDAQ:MRAM) rating on Wednesday, November 2. Needham has “Strong Buy” rating and $10.0 target.

Wesbanco Bank Inc increased Bristol (BMY) stake by 8.53% reported in 2017Q2 SEC filing. Wesbanco Bank Inc acquired 38,337 shares as Bristol (BMY)’s stock declined 1.04%. The Wesbanco Bank Inc holds 487,707 shares with $27.18M value, up from 449,370 last quarter. Bristol now has $100.25 billion valuation. The stock declined 0.82% or $0.5 reaching $60.75 on the news. About 41,362 shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since November 15, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Everspin Technologies, Inc. is a United States well-known provider of magnetoresistive random-access memory solutions. The company has market cap of $104.69 million. The Firm is engaged in designing, manufacturing and shipping discrete and embedded MRAM and spin-torque MRAM (ST-MRAM) into markets and applications. It currently has negative earnings. The Company’s products include 8-bit/16-bit Parallel Interface MRAM, Serial Peripheral Interface (SPI), Quad SPI and Double Data Rate (DDR) 3 dynamic random-access memory (DRAM) Compatible MRAM – Spin Torque Technology.

The stock decreased 14.14% or $1.36 on November 14, reaching $8.26. About shares traded. Everspin Technologies Inc (MRAM) has 0.00% since November 15, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 67 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Monday, January 25 by BMO Capital Markets. Jefferies maintained the shares of BMY in report on Thursday, August 27 with “Hold” rating. Credit Suisse maintained Bristol-Myers Squibb Co (NYSE:BMY) rating on Monday, May 9. Credit Suisse has “Outperform” rating and $79 target. UBS upgraded the shares of BMY in report on Tuesday, September 29 to “Buy” rating. Piper Jaffray maintained the shares of BMY in report on Thursday, July 27 with “Hold” rating. The firm has “Buy” rating by Citigroup given on Wednesday, October 18. The firm earned “Hold” rating on Friday, September 22 by Piper Jaffray. Jefferies maintained the shares of BMY in report on Monday, July 17 with “Buy” rating. On Monday, July 17 the stock rating was maintained by Deutsche Bank with “Hold”. The company was downgraded on Tuesday, September 12 by Hilliard Lyons.

Wesbanco Bank Inc decreased Microsoft (NASDAQ:MSFT) stake by 54,336 shares to 356,247 valued at $24.56 million in 2017Q2. It also reduced Boeing (NYSE:BA) stake by 18,454 shares and now owns 126,771 shares. Honeywell (NYSE:HON) was reduced too.

Investors sentiment decreased to 0.95 in 2017 Q2. Its down 0.03, from 0.98 in 2017Q1. It worsened, as 78 investors sold BMY shares while 520 reduced holdings. 120 funds opened positions while 451 raised stakes. 1.10 billion shares or 2.26% less from 1.12 billion shares in 2017Q1 were reported. Moreover, New South Cap Management Inc has 0.01% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 8,312 shares. Regentatlantic Cap Limited Com invested 0.07% in Bristol-Myers Squibb Co (NYSE:BMY). Ardevora Asset Management Ltd Liability Partnership has 469,100 shares. Jacobs Levy Equity Mngmt holds 18,190 shares or 0.02% of its portfolio. Focused Wealth Mgmt holds 11,105 shares. Old Mutual Customised Solutions (Proprietary) holds 0.5% or 60,668 shares in its portfolio. Westend Limited Co holds 0% or 926,621 shares. Arrow Corp has 0.46% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 34,135 shares. Gru accumulated 531,698 shares. Liberty Management holds 1,400 shares or 0.05% of its portfolio. Sns Finance Group Lc holds 0.08% in Bristol-Myers Squibb Co (NYSE:BMY) or 5,269 shares. Gideon Advsrs invested in 0.23% or 3,686 shares. Cetera Limited has invested 0.24% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Iowa Commercial Bank reported 53,230 shares. 6,410 were reported by Cap Ltd Llc.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.